BNZ-2

N/A

Report date: 2023/12/28 13:58:00
NMEFirst In Class

Base Information

Drug NameBNZ-2
Drug Alias NameEQ102EQ-102BNZ-2
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin-15 inhibitorsInterleukin-21 inhibitors
TargetsInterleukin-15Interleukin-21
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioniz Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEquillium Inc
Inactive CompaniesN/A
Active IndicationsInflammationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A